Identification of SARS-CoV-2 E Channel Blockers from a Repurposed Drug Library
SARS-CoV-2, the etiological agent of the COVID-19 pandemic, is a member of the Coronaviridae family. It is an enveloped virus with ion channels in its membrane, the most characterized of which is the E protein. Therefore, in an attempt to identify blockers of the E channel, we screened a library of...
Saved in:
Main Authors: | Prabhat Pratap Singh Tomar (Author), Miriam Krugliak (Author), Isaiah T. Arkin (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting Viral Ion Channels: A Promising Strategy to Curb SARS-CoV-2
by: Anamika Singh, et al.
Published: (2022) -
SARS-CoV-2: Virology and Drug Repurposing Approaches
by: Ratika Rahmasari, et al.
Published: (2020) -
Rapamycin: Drug Repurposing in SARS-CoV-2 Infection
by: Jiri Patocka, et al.
Published: (2021) -
Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors
by: Wei-Chung Chiou, et al.
Published: (2021) -
Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets
by: Pei-Chen Yu, et al.
Published: (2022)